Home » FDA Looks Into Possible Opioid, OTC Mix-Up at Novartis Plant
FDA Looks Into Possible Opioid, OTC Mix-Up at Novartis Plant
The FDA is looking into possible commingling of OTC drugs and prescription opioids at a Novartis Consumer Health plant as it works with the company to fix manufacturing problems there.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May